No disrespect taken. Likewise, let me ask: Are you familiar at all with their product pipeline? And are you aware of the Epipen crises (last year a cost issue, this month a shortage issue)? Of course they are cash negative, all they have been doing is R & D. Now they have a MAJOR fda approved product ready for a Major market, but have been horrible at executing a partner deal. By the way, Maxim just last week changed their PT for this from 5 to 10. Many long term watchers feel it's now or never (by mid Juneish).
News 
Market Data 
Discover 
